Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Dr Andreas Konieczny on leading with authenticity
Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.
Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny
In this episode of GOLD podcast, the latest catalyst ImmunoGen’s Andreas Konieczny offers insights on driving drug launches and leadership skills. Listen now!
23rd October 2023
A podcast exploring the DaBlaCa-13 study, chemoresection with dose-dense mitomycin C (MMC) in patients with recurrent non-muscle-invasive bladder cancer (intermediate-risk)
Tune in for a fascinating discussion with Jørgen Bjerggaard Jensen, as he explores recent breakthroughs in non-muscle-invasive bladder cancer management through mitomycin C (MMC) chemoresection.
1
Mins
23rd October 2023
Inflammatory-Related Diseases an Early Sign of Type 2 Diabetes?
The present study assessed the clinical histories of pre- and post-Type 2 Diabetes diagnoses with the aim of gaining insight into causes and trajectories for health-related conditions, such as cardiovascular and pulmonary disorders.
1
Mins
23rd October 2023
Sudden Cardiac Arrest in Patients with Type 2 Diabetes
New research has identified a range of characteristics associated with an increased risk of sudden cardiac arrest in patients with Type 2 diabetes. However, it remains difficult to predict, especially in those without a history of cardiovascular disease.
20th October 2023
Navigating the Complexities of Metastatic Colorectal Cancer: From Genetic Mutations to Targeted Therapies
Two experts in medical oncology explore the latest developments in metastatic colorectal cancer in this episode of the EMJ podcast.
1
Mins
20th October 2023
Does a History of Cancer Increase Hearing Loss Risk?
According to research, the risk of hearing loss is greater in individuals who are survivors of cancer. This is due to age and the effects of previous chemotherapy and radiotherapy. Read more.
1
Mins
20th October 2023
Lung Cancer: Disparities in Incidence Rates
Incidence rates for lung cancer in US females aged 35-54 were higher than in males and older females, according to research by Ahmedin Jemal, American Cancer Society, Atlanta, Georgia, USA, and colleagues.
19th October 2023
Healthcare Inequalities and the Exposome
Michelle Kelly-Irving joins Jonathan to speak about social, economic, and gender inequalities in healthcare, as well as the exposome.
7
Mins
19th October 2023
Atypical Hepatitis B-Associated Vasculitis
One of the many extra-hepatic manifestations of hepatitis B virus (HBV) infections is vasculitis. While the classic HBV-associated…
←
1
2
3
…
141
142
143
144
145
146
147
…
898
899
900
→